Hyperactivation of MAPK Signaling Is Deleterious to RAS/RAF-mutant Melanoma

Leung, GP; Feng, TS; Sigoillot, FD; Geyer, FC; Shirley, MD; Ruddy, DA; Rakiec, DP; Freeman, AK; Engelman, JA; Jaskelioff, M; Stuart, DD

Jaskelioff, M (reprint author), Novartis Inst BioMed Res, Oncol, Cambridge, MA 02139 USA.; Stuart, DD (reprint author), Novartis Inst BioMed Res, 250 Massachusetts Ave, Cambridge, MA 02139 USA.

MOLECULAR CANCER RESEARCH, 2019; 17 (1): 199